Moderna Teams Up with OpenAI to Propel mRNA Medicine Innovation
Moderna, Inc. (NASDAQ: MRNA) and OpenAI have announced a collaborative effort aimed at harnessing the potential of artificial intelligence (AI) to revolutionize both business and healthcare. Moderna, known for its…
CVS Health Allocates $19.2 Million Towards Affordable Housing in Arvada, Colorado
CVS Health® (NYSE: CVS) revealed today a significant investment of $19.2 million, facilitated via Boston Financial, earmarked for the construction of 85 new affordable housing units in Arvada, Colorado. This…
Native Health Navigator Program Connects Tribes to Cancer Care
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics have announced an exclusive licensing agreement, granting Vertex access to TreeFrog’s cutting-edge cell manufacturing technology, C-Stem™. This collaboration aims to optimize the…
Vertex, TreeFrog Therapeutics Collaborate to Enhance Cell Therapy Production for Type 1 Diabetes
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics have announced an exclusive licensing agreement, granting Vertex access to TreeFrog’s cutting-edge cell manufacturing technology, C-Stem™. This collaboration aims to optimize the…
Roche Q1 Sales Up 2% (CER), Both Divisions Show High Single-Digit Growth Excluding COVID-19
Roche Reports 2% Growth in Group Sales Despite Currency Impact In the first quarter of 2024, Roche saw a 2% increase in group sales at constant exchange rates (CER), though…
Novel Malaria Treatment Shows Positive Results for Infants <5kg: Novartis & Medicines for Malaria Venture
Novartis and Medicines for Malaria Venture (MMV) have unveiled encouraging results from their phase II/III CALINA trial, indicating that a newly formulated version of Coartem® (artemether-lumefantrine) tailored for infants weighing…
EU Approves Vaidya as Additional Therapy for Adults with PNH and Persistent Haemolytic Anaemia Despite Rovelizumab or Eculizumab Treatment
Voydeya (danicopan) Receives EU Approval as Supplemental Treatment for Adults with PNH and Residual Hemolytic Anemia Voydeya (danicopan) has gained approval in the European Union (EU) to be used alongside…
Join Allergan Aesthetics in Becoming the Ambassador for BOTOX® Cosmetic and Their Leading Brands
Allergan Aesthetics, a division of AbbVie (NYSE: ABBV), is extending an invitation to consumers to participate in future campaigns featuring their flagship brands, such as BOTOX® Cosmetic, the JUVÉDERM® Collection…
Positive Phase 2 Results for NBI-1065845 in Adult Major Depression
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) has unveiled positive top-line results from its Phase 2 SAVITRI™ trial. This study, employing a randomized, double-blind, and placebo-controlled design, evaluated the efficacy and safety…
Tomi Pitkäniemi and Nikolas Kusto Discuss How Effective Automation Boosts Medicinal Quality and Orion’s Competitive Edge
When a patient chooses a medication crafted by Orion, they can trust they’re receiving precisely the indicated dosage of active ingredients,” highlights Tomi Pitkäniemi, Automation Manager, underlining the critical role…
Lupin’s Aurangabad Manufacturing Facility Granted EIR by U.S. FDA
Lupin, a global pharmaceutical giant, proudly announces the reception of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its manufacturing facility in…
Moderna Secures Deal to Provide 12.5 Million COVID-19 Vaccines for Brazil’s National Vaccination Drive
Moderna, Inc. (NASDAQ: MRNA) has announced a significant milestone in its global efforts to combat COVID-19 by securing a contract with Brazil’s Ministry of Health (Ministério da Saúde). The contract…